$5.22 +0.02 (%) MannKind Corp - NASDAQ

Apr. 1, 2015 | 04:00 PM

Partner Headlines

  1. Goldman Sachs Slams MannKind, Shares Down 9%

    Benzinga | Mar. 3, 2015 | 11:52AM EST
  2. MannKind's Short Interest Has 'Grown High,' Analyst Says

    Benzinga | Mar. 3, 2015 | 10:47AM EST
  3. Goldman Sachs Says MannKind Has 55% Downside

    Benzinga | Mar. 3, 2015 | 10:07AM EST
  4. Morning Market Losers

    Benzinga | Mar. 3, 2015 | 10:02AM EST
  5. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 3, 2015 | 08:23AM EST
  6. Jefferies Expects Exciting 2015 For MannKind

    Benzinga | Feb. 26, 2015 | 10:56AM EST
  7. JPM Securities Picks Through Biotech News For Winners

    Benzinga | Feb. 25, 2015 | 12:41PM EST
  8. MannKind's Accounting Is 'Murky,' MLV Analyst Says

    Benzinga | Feb. 25, 2015 | 10:15AM EST
  9. MannKind Corporation Posts In-Line Q4; Expense Falls 35%

    Benzinga | Feb. 24, 2015 | 17:34PM EST
  10. Earnings Scheduled For February 24, 2015

    Benzinga | Feb. 24, 2015 | 04:57AM EST
  11. MannKind Adds To Wednesday's Gains, Back Above $7

    Benzinga | Feb. 5, 2015 | 11:44AM EST
  12. Another Reason MannKind Could Be Up (In 1 Tweet)

    Benzinga | Jan. 26, 2015 | 16:15PM EST
  13. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  14. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  15. Griffin Securities Analyst Thinks New MannKind Management Will Focus On R&D, Not Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  16. Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  17. MannKind Founder Becomes Chairman, President Hakan Edstrom Becomes New CEO

    Benzinga | Jan. 12, 2015 | 08:26AM EST
  18. What to Watch for: November 3-7

    GuruFocus | Nov. 4, 2014 | 11:39AM EST
  19. Earnings Scheduled For November 3, 2014

    Benzinga | Nov. 3, 2014 | 05:18AM EST
  20. NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results

    Benzinga | Sep. 25, 2014 | 12:09PM EST
  21. Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss

    Benzinga | Sep. 25, 2014 | 11:12AM EST
  22. Benzinga's Top Initiations

    Benzinga | Aug. 27, 2014 | 09:26AM EST
  23. Jefferies Initiates MannKind At Buy, Shares Rise

    Benzinga | Aug. 27, 2014 | 08:23AM EST
  24. Roche to Acquire InterMune and Deliver Hope to Patients Worldwide

    GuruFocus | Aug. 25, 2014 | 11:16AM EST
  25. Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza

    GuruFocus | Aug. 15, 2014 | 09:59AM EST
  26. There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune

    GuruFocus | Aug. 14, 2014 | 16:38PM EST
  27. Zynga Goes Out To Pasture; Kinder Morgan Combines Companies

    Benzinga | Aug. 11, 2014 | 14:51PM EST
  28. Dean Foods Dips On Q2 Results; Kinder Morgan Shares Spike Higher

    Benzinga | Aug. 11, 2014 | 12:44PM EST
  29. Markets Open Higher; Priceline Issues Downbeat Profit Forecast

    Benzinga | Aug. 11, 2014 | 11:32AM EST
  30. Stocks Higher, Nasdaq Leads; Kinder Morgan, Priceline Rising

    IBD | Aug. 11, 2014 | 10:31AM EST
  31. Morning Market Movers

    Benzinga | Aug. 11, 2014 | 09:45AM EST
  32. MannKind Up 20% On Diabetes Deal With Sanofi

    Benzinga | Aug. 11, 2014 | 09:18AM EST
  33. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 11, 2014 | 08:05AM EST
  34. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Aug. 11, 2014 | 07:44AM EST
  35. Sanofi and MannKind Announce Global Licensing Agreement for Afrezza (insulin human) Rapid-Acting Inhaled Insulin

    Benzinga | Aug. 11, 2014 | 07:04AM EST
  36. What This Upcoming Monday Means For MannKind Shareholders

    GuruFocus | Aug. 8, 2014 | 19:32PM EST
  37. Morning Market Movers

    Benzinga | Aug. 6, 2014 | 09:47AM EST
  38. Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market

    GuruFocus | Jul. 29, 2014 | 17:50PM EST
  39. Mannkind Corporation: Safe Labeling, Incentivized Spirometry and Experts Votes of Confidence

    GuruFocus | Jul. 25, 2014 | 18:59PM EST
  40. Mannkind Corporation: Why Afrezza Would Completely Dominate The Insulin Market

    GuruFocus | Jul. 16, 2014 | 19:22PM EST
  41. A Look at Mannkind Corporation's True Value

    GuruFocus | Jul. 2, 2014 | 19:02PM EST
  42. Morning Market Losers

    Benzinga | Jul. 1, 2014 | 09:46AM EST
  43. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 1, 2014 | 08:12AM EST
  44. UPDATE: MLV & Co. Downgrades MannKind On Fair Valuation

    Benzinga | Jul. 1, 2014 | 07:56AM EST
  45. Markets Little Changed As The Quarter Comes To An End

    Benzinga | Jun. 30, 2014 | 16:34PM EST
  46. General Motors Issues More Recalls, Reach 27 Million Autos Recalled In 2014

    Benzinga | Jun. 30, 2014 | 15:52PM EST
  47. MannKind Jumps On FDA Approval; Rayonier Shares Slide

    Benzinga | Jun. 30, 2014 | 13:58PM EST
  48. RBC Looks For Post-Approval Data On MannKind

    Benzinga | Jun. 30, 2014 | 12:37PM EST
  49. Markets Edge Higher; PPG To Acquire Comex For $2.3 Billion

    Benzinga | Jun. 30, 2014 | 10:29AM EST
  50. Benzinga's Volume Movers

    Benzinga | Jun. 30, 2014 | 10:26AM EST
Trading Center